In case you missed it, our webinar is now available for streaming. Click the video below




APUA President Levy attends "White House Forum on Antibiotic Stewardship"

The summit, the first of its kind, was attended by 150+ leaders of the health, food, and agriculture industries on June 2, 2015. The event was buttressed by the signing of a Presidential Memorandum that creates Federal preference for meat and poultry that are produced with responsible antibiotic use. The various attendees made commitments to abide by the standards set forth by the recently-published National Action Plan for Combating Antibiotic-Resistance Bacteria. Read APUA's commitment here

APUA Newsletter Vol. 33. No. 3
"Innovative approaches to confront the antibiotic resistance crisis"


Antibiotics are humanity's key defense against disease-causing microbes. The growing prevalence of antibiotic resistance threatens a future where these drugs can no longer cure infections and killer epidemics run rampant. The Alliance for the Prudent Use of Antibiotics (APUA) has been the leading global non-governmental organization fighting to preserve the effectiveness of antimicrobial drugs since 1981. With affiliated chapters in over 66 developed and developing countries, we conduct research, education and advocacy programs to control antimicrobial resistance and ensure access to effective antibiotics for current and future generations. For more information on antibiotic resistance research, visit our partner lab at the Center for Adaptation Genetics and Drug Resistance.

Antibiotic Resistance
in the News

WHO Worldwide Country Situational Analysis: Response to Antimicrobial Resistance

The National Action Plan for Combating Antibiotic-Resistant Bacteria, 2015

2014 PCAST Report on 
Combating Antimicrobial Resistance






Public Health AdvocacyGlobal Research and Survellience

Consumer and Practioner ResourcesAPUA Chapters

"Antibiotics are uniquely societal drugs because individual use affects others in the community and environment.  Better stewardship, incentives, and establishment of a special regulatory category will improve how they are used, marketed, and developed through incentives to industry."

Stuart B. Levy, M.D.
President of APUA, professor at Tufts University School of Medicine

From the IOM 25th Anniversary Symposium (1996) and The Antibiotic Paradox (2002)

2014 Alliance for the Prudent Use of Antibiotics | 136 Harrison Ave, M&V Suite 811, Boston, MA, 02111 | Tel 617.636.0966 | apua@tufts.eduHome | Search | Contact Us